Entry |
|
Name |
Glyclopyramide (JAN/INN); Deamelin-S (TN) |
Formula |
C11H14ClN3O3S
|
Exact mass |
303.0444
|
Mol weight |
303.77
|
Structure |

|
Class |
|
Remark |
Therapeutic category: | 3961 |
|
Efficacy |
Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist |
Comment |
Sulfonylurea
|
Target |
|
Pathway |
|
Interaction |
|
Structure map |
map07018 | Sulfonamide derivatives - hypoglycemic agents |
|
Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3961 Sulfonylureas
D01799 Glyclopyramide (JAN/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG01508 Sulfonylurea receptor agonist
DG01734 Sulfonylurea
D01799 Glyclopyramide
DG02044 Hypoglycemic agent
DG01734 Sulfonylurea
D01799 Glyclopyramide
Drug classes [BR:br08332]
Antidiabetic agent
DG01734 Sulfonylurea
D01799 Glyclopyramide
DG02044 Hypoglycemic agent
D01799 Glyclopyramide
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
ABCC8 (SUR1)
D01799 Glyclopyramide (JAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 19
1 C8x C 10.8910 -17.8271
2 C8y C 10.8910 -19.2312
3 C8x C 12.0845 -19.9333
4 C8x C 13.2780 -19.2312
5 C8y C 13.2780 -17.8271
6 C8x C 12.0845 -17.1251
7 X Cl 9.6273 -19.9333
8 S4a S 14.4996 -17.1282
9 N1b N 15.7114 -17.8342
10 O3c O 15.4896 -16.1383
11 O3c O 13.5097 -16.1383
12 C5a C 16.8961 -17.1564
13 N1b N 18.0835 -17.8482
14 O5a O 16.9017 -15.7504
15 N1y N 19.2801 -17.1635
16 C1x C 20.5834 -17.5766
17 C1x C 21.3820 -16.4671
18 C1x C 20.5735 -15.3648
19 C1x C 19.2753 -15.7930
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 6 1 1
7 2 7 1
8 5 8 1
9 8 9 1
10 8 10 2
11 8 11 2
12 9 12 1
13 12 13 1
14 12 14 2
15 13 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 15 19 1
|